Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M. (René) van Hulst

Publicaties

A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe

A situational and stakeholder analysis of health technology assessment in Zimbabwe

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland

Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence

Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review

Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants

Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands

The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings

Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia

Lees meer